Error loading player: No playable sources found
2165
Artificial Intelligence in GI Cancer Screening and Therapeutics
Date
May 18, 2024
This product is not available for individual purchase, but it is available as part of the following products:
Full DDW 2024 On Demand Program available now!
SOCIETY: AGA Join this session to review current and future applications for AI in assessing GI cancer risk, and guiding cancer screening and cancer therapeutics in research and clinical care settings.
Presentations:
| AI & MACHINE LEARNING PRIMER IN GI CANCER |
| AI IN ENDOSCOPY FOR SCREENING AND SURVEILLANCE |
| MACHINE LEARNING APPLICATIONS FOR GI CANCER BIOMARKER DISCOVERY |
| MACHINE LEARNING ANALYSIS OF ENDOSCOPIC ULTRASONOGRAPHY TEXTURE AND CLINICAL INFORMATION PREDICTS PANCREATIC NEOPLASTIC PROGRESSION IN HIGH-RISK INDIVIDUALS WITHIN 18 MONTHS |
| A CIRCRNA BASED-LIQUID BIOPSY FOR NONINVASIVE AND EARLY DETECTION OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA |
| USE OF DEEP LEARNING TO EVALUATE TUMOR MORPHOLOGICAL FEATURES FOR PREDICTION OF COLON CANCER RECURRENCE |
Moderators
Columbia University Medical Center
University of Michigan
Speakers
Beckman Research Institute, City of Hope Comprehensive Cancer Center
Johns Hopkins Hospital
Tracks
Related Products
AI Applications in GI Disorders
SOCIETY: AGA AI, automation, GI disorders
AI: The Next Frontier in Reshaping Practice
AI: WHERE IS THE ROAD TAKING US?
Third Space Endoscopy: Quo Vadis
IMPACT OF FRAILTY ON PER ORAL ENDOSCOPIC MYOTOMY(POEM): A NATIONAL DATABASE ANALYSIS
